 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              PRICING BOTTOMED OUT; STRONG VOLUMES
Mphasis reported Q4FY10 with 7.5%QoQ USD revenue growth which was in line with most of its peers.
* Adequate volume growth and stable pricing
* APO outperforms, ITO disappoints on margins
* Robust growth in APAC; large client win in telecom
Outlook – Pricing re-negotiation, strong hiring and higher volumes from non HP business – Mphasis is expected to renegotiate prices with HP in various segments, which would enhance growth in FY11. The company has 1,600 and 800 open positions in the APO and ITO segment. Volumes from non-HP business are expected to improve on new client wins. MphasiS has performed well during this fiscal despite price cuts in the HP-driven business. We expect volume-led growth ahead of peers within the mid-cap space. MphasiS also has better operating margins and higher return ratios compared with peers.
The stock is trading at 10.8x FY12E EPS. We maintain 'BUY' recommendation with target price of Rs780 based on 14xFY12E.